Vasodilating effect of di-peptides in thoracic aortas from spontaneously hypertensive rats

Bioscience, Biotechnology and Biochemistry

Volumn 70, Issue 9, 2006, Pages 2292-2295

  Tanaka, Mitsuru ^a   Matsui, Toshiro ^a   Ushida, Yusuke ^a   Matsumoto, Kiyoshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

ACE; Hypertension; Small peptides; Spontaneously hypertensive rat (SHR) aorta; Vascular relaxation

Indexed keywords

ACE; HYPERTENSION; SMALL PEPTIDES; SPONTANEOUSLY HYPERTENSIVE RAT (SHR) AORTA; VASCULAR RELAXATION;

BIODIVERSITY; BIOLOGICAL ORGANS; ENZYME INHIBITION; MUSCLE;

AMINO ACIDS;

ANTIHYPERTENSIVE AGENT; DIPEPTIDE; ISOLEUCYL TYROSINE; ISOLEUCYL-TYROSINE; VALYLTYROSINE; VASODILATOR AGENT;

ANIMAL; ARTICLE; DRUG EFFECT; IN VITRO STUDY; MALE; MUSCLE CONTRACTION; PHYSIOLOGY; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; THORACIC AORTA; VASODILATATION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; AORTA, THORACIC; DIPEPTIDES; MALE; MUSCLE CONTRACTION; RATS; RATS, INBRED SHR; VASODILATION; VASODILATOR AGENTS;

EID: 33749036553     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.60119     Document Type: Article

References (10)

1. Matsui, T., and Matsumoto, K., Lead molecules from natural products: discovery and trends. In "Antihypertensive Peptides from Natural Resources" Chapter 15, eds. Khan, M. T. H., and Ather, A., Elsevier, The Netherlands, pp. 259-276 (2006).
2. Kawasaki, T., Seki, E., Osajima, K., Yoshida, M., Asada, K., Matsui, T., and Osajima, Y., Antihypertensive effect of valyl-tyrosine, a short chain peptide derived from sardine muscle hydrolyzate, on mild hypertensive subjects. J. Human Hypertens., 14, 519-523 (2000).
3. Hata, Y., Yamamoto, M., Ohni, M., Nakashima, K., Nakamura, Y., and Takano, T., A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. Am. J. Clin. Nutr., 64, 767-771 (1996).
4. Matsui, T., Hayashi, A., Tamaya, K., Matsumoto, K., Kawasaki, T., Murakami, K., and Kimoto, K., Depressor effect induced by dipeptide, Val-Tyr, in hypertensive transgenic mice is due, in part, to the suppression of human circulating renin-angiotensin system. Clin. Exp. Pharm. Physiol., 30, 262-265 (2003).
5. 2+ channel inhibition in cultured vascular smooth muscle cells. Hypertension Res., 28, 545-552 (2005).
6. Damiani, C. E. N., Rossoni, L. V., and Vassallo, D. V., Vasorelaxant effects of eugenol on rat thoracic aorta. Vascular Pharmacol., 40, 59-66 (2003).
7. Matsufuji, H., Matsui, T., Seki, E., Osajima, K., Nakashima, M., and Osajima, Y., Angiotensin I-converting enzyme inhibitory peptides in an alkaline protease hydrolyzate derived from sardine muscle. Biosci. Biotechnol. Biochem., 58, 2244-2245 (1994).
8. Matsui, T., Yukiyoshi, A., Doi, S., Sugimoto, H., Yamada, H., and Matsumoto, K., Gastrointestinal enzyme production of bioactive peptides from royal jelly protein and their antihypertensive ability in SHR. J. Nutr. Biochem., 13, 80-86 (2002).
9. Akpaffiong, M. J., and Tayler, A. A., Antihypertensive and vasolidator actions of antioxidants in spontaneously hypertensive rats. Am. J. Hypertens., 11, 1450-1460 (1998).
10. Ririe, D. G., Roberts, P. R., Shouse, M. N., and Zaloga, G. P., Vasodilatory actions of the dietary peptide carnosine. Nutrition, 16, 168-172 (2000).